跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CAR T-cell therapy (lung cancer)
首页
药物
CAR T-cell therapy (lung cancer)
CAR T-cell therapy (lung cancer)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Dual target CAR-T therapy vector for lung cancer and construction method and application of dual target CAR-T therapy vector
申请人: SHANGHAI YIHAO BIOTECHNOLOGY CO LTD
优先权: 2018
CN
Low-expression TSC22D3 enhanced CAR T cell and application thereof
申请人: THE FIRST AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV GUANGZHOU RESPIRATORY CENTER
优先权: 2025
CN
METHODS FOR THE DETECTION AND TREATMENT OF RESISTANT CANCERS CO-EXPRESSING ALPP AND/OR ALPG/ALPPL2
申请人: UNIV TEXAS
优先权: 2023
EP
WO
2 件公开
Chimeric antigen receptor fusion protein targeting SIRP gamma, CAR-T cell and application of chimeric antigen receptor fusion protein and CAR-T cell in lung cancer treatment
申请人: SICHUAN PROVINCIAL PEOPLES HOSPITAL SICHUAN ACAD OF MEDICAL SCIENCES
优先权: 2025
CN
Construction method of animal model for synergistically treating small cell lung cancer by mutant cells and Venotog
申请人: SHANGHAI CHEST HOSPITAL
优先权: 2025
CN
USE OF ICARISIDE I IN TREATMENT OR PREVENTION OF MICROSATELLITE-STABLE SOLID TUMORS AND KIT CONTAINING SAME
申请人: GOLDEN HEALTH GUANGDONG BIOTECHNOLOGY CO LTD
优先权: 2023
WO
Nanometer antibody targeting CD276 and application thereof
申请人: CYTOTECH BIOPHARMA INC
优先权: 2024
CN
Nanometer antibody specifically combined with CD276 and application thereof
申请人: CYTOTECH BIOPHARMA INC
优先权: 2024
CN
药物
反馈